Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials
Diabetes, Obesity and Metabolism · 2026-09 · 28 (9) · 8693-8696
DOI: 10.1111/dom.70980 ↗At a glance
Leserbrief in Diabetes, Obesity and Metabolism, published online on 2026-06-15. Written by Cho-Han Chiang and 5 co-authors. Institution: Northwell Health Cancer Institute, New Hyde Park, New York, USA. 12 references. The full text is freely available in PubMed Central.
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
Author keywords
Authors and institutions
- Northwell Health Cancer Institute, New Hyde Park, New York, USA.
- Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts, USA.
- Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA.
- Department of Medicine, University at Buffalo-Catholic Health System, Buffalo, New York, USA.
- Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
ORCID profiles: Cho-Han Chiang, Furkan Bahar
Cite
APA
Chiang, C. H., Bahar, F., Chang, Y. C., Wang, T. H., Hsia, Y. P., & Chiang, C. H. (2026). Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials. Diabetes, Obesity and Metabolism, 28(9), 8693-8696. https://doi.org/10.1111/dom.70980
Vancouver
Chiang CH, Bahar F, Chang YC, Wang TH, Hsia YP, Chiang CH. Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials. Diabetes, Obesity and Metabolism. 2026;28(9):8693-8696. doi:10.1111/dom.70980
BibTeX
@article{Chiang2026,
author = {Chiang, Cho-Han and Bahar, Furkan and Chang, Yu-Cheng and Wang, Tsu Hsien and Hsia, Yuan Ping and Chiang, Cho-Hung},
title = {Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {9},
pages = {8693--8696},
doi = {10.1111/dom.70980}
}
EUVIMED